Novakand Pharma AB (publ) (STO:NOVKAN)
Sweden · Delayed Price · Currency is SEK 0.1090
-0.0102 (-8.56%)
Mar 4, 2026, 5:09 PM CET
Novakand Pharma AB Market Cap
Novakand Pharma AB has a market cap or net worth of 13.21 million as of March 4, 2026. Its market cap has decreased by -89.27% in one year.
Market Cap
13.21M
Enterprise Value
-2.86M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since February 28, 2011, Novakand Pharma AB's market cap has decreased from 90.09M to 13.21M, a decrease of -85.34%. That is a compound annual growth rate of -12.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 13.21M | -30.31% |
| Dec 30, 2025 | 18.95M | -85.70% |
| Dec 30, 2024 | 132.58M | -64.21% |
| Dec 29, 2023 | 370.44M | 119.29% |
| Dec 30, 2022 | 168.93M | -50.92% |
| Dec 30, 2021 | 344.16M | -51.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ExpreS2ion Biotech Holding AB | 53.73M |
| AcouSort AB | 52.06M |
| 2cureX AB | 40.29M |
| Modus Therapeutics Holding AB | 35.27M |
| Nanologica AB | 33.85M |
| Guard Therapeutics International AB | 33.68M |
| Fluicell AB | 18.00M |
| Aptahem AB | 16.82M |